FDA Raises Considerations About Perrigo’s Opill Delivery Management Drug for OTC Gross sales

The FDA is reviewing the opportunity of Perrigo’s Opill contraception being bought over-the-counter. Nevertheless, issues have been raised about its security and effectiveness and not using a doctor’s prescription.

[ad_1]

Unique Supply: https://www.parentherald.com/articles/110077/20230506/fda-raises-concerns-perrigos-opill-birth-control-drug-otc-sales.htm
Written by: on 2023-05-06 12:51:56

[ad_2]